Horizon Pharma PLC (NASDAQ:HZNP) Receives Notice of Allowance From U.S. Trademark And Patent Office

Horizon Pharma PLC (NASDAQ:HZNP) has announced that it has received a notice of allowance from the U.S. Trademark and Patent Office. It is a well-known specialty biopharmaceutical company with the primary objective of improving the lives of patients by offering different products and services. Management’s Call On The Notice of Allowance: Horizon Pharma is active […]

Horizon Pharma PLC (NASDAQ:HZNP) Gets Orphan-Drug Designation for ACTIMMUNE(R)

Boston, MA 10/06/2014 (wallstreetpr) – According to reports, US Food and Drug Administration has granted Horizon Pharma PLC (NASDAQ:HZNP) the orphan-drug designation for ACTIMMUNE(R). HZNP is a well know biopharmaceutical company and offers various products for inflammation, arthritis and orphan diseases. ACTIMMUNE(R) is an interferon gamma-1b drug which is used for the treatment of Friedreich’s ataxia […]